Work

Impact of availability of a highly effective cystic fibrosis treatment (elexacaftor/tezacaftor/ivacaftor) on lung transplant waitlist and lung transplantation trends in the US

Year: 2025

Type: article

Study design: Observational Study

Source: Respiratory Medicine

DOI: 10.1016/j.rmed.2025.108171

Authors: Christian Merlo, Jessica Morlando Geiger, Zailong Wang, Grace R. Lyden, David P. Schladt, Lisa McGarry

Institutions: Johns Hopkins University, Vertex Pharmaceuticals (United States), Hennepin Healthcare Research Institute

Language: English

Topic: Transplantation: Methods and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410552134

FWCI: 4.661

Cites: 28

Cited by: 5

Related to: 10